Medical Writing Public Disclosure Lay titles for clinical trials: A balancing act

Volume 27, Issue 2 - Public Disclosure

Lay titles for clinical trials: A balancing act


With increasing transparency demands andthe new legal requirements for providingclinical trial information to lay readers, clinicaltrials need to be given titles that patients canunderstand and recognise. Trial titles informthe readers what the trial is about, whatsubstances are studied, and who the targetpopulation is. Devising a lay title is challengingas it needs to be understandable to lay readers,fully identify the trial, meet registryrequirements, and also be translatable intodifferent languages. Lay titles also need to fitdifferent types of documents, e.g. trialprotocols, trial advertisements, informedconsent forms, and lay summaries. As the laytitle is one of the first pieces of informationthat is displayed, good lay titles help patientssearching clinical trial registries for trialparticipation. For sponsors, informative andunderstandable lay titles increase the chancesof attracting the target patient populations forclinical trials.

Download the full article


  1. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine 2010;8:18.
  2. World Medical Association General Assembly. 2013. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects [cited 20 Mar 2018]. Available from: Available from:
  3. Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al. Data sharing statements for clinical trials - a requirement of the International Committee of Medical Journal Editors. JAMA. 2017;317(24): 2491–2.
  4. World Health Organization (WHO). International Clinical Trial Registry Platform Trial Registration Data Set (Version 1.3) [cited 20 Mar 2018]. Available from: Available from:
  5. Public law: Food and Drug Administration Amendments Act of 2007. US Public Law 110-185. (2007, Sept 27); 21 USC 301.
  6. Protocol Registration Data Element Definitions for Inter ventional and Observational Studies (2017, June 29) [cited 20 Mar 2018]. Available from:
  7. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014.
  8. National Institutes of Health, Department of Health and Human Services. Clinical Trials Registration and Results Information Submission; Final Rule (2016, Sept 21). 81 FR 64981; 42 CFR Part 11.
  9. Grant MJ. What makes a good title? Health Info Libr J. 2013;30:259–260.
  10. Schultz DM. Eloquent Science: A Practical Guide to Becoming a Better Writer, Speaker and Scientist. Chapter 3: Writing an Effective Title. 2nd ed. Boston (MA): American Meteorological Society; 2009.
  11. Saenz C, Reveiz L, Tisdale JF. Public titles of clinical trials should have ethics review. J Clin Epidemiol. 2015;68:1105–1107.
  12. Review of Protocol Submissions [cited 20 Mar 2018]. Available from: Available from:
  13. Salita JT. Writing for lay audiences: A challenge for scientists. Med Writing. 2015;24(4):183–189.



President’s Message
The Regulatory Public Disclosure Special Interest Group
Clinical trial disclosure and transparency
Navigating the EMA clinical data website
Anonymisation reports from 2016 to 2017: A preliminary analysis
Preparing anonymisation reports in general and for an orphan drug in particular
Policies 0070 and 0043: Juggling different requirements
Clinical data publication by the EMA: The challenges facing the pharmaceutical industry
Clinical trial results disclosure on and EudraCT
Writing lay summaries: What medical writers need to know
Lay titles for clinical trials: A balancing act
Why clinical study reports really matter
CORE Reference – a tool for modern clinical study reports in an era of increasing transparency and disclosure
Preparing clinical study reports for external sharing
Harmonising format and style requirements for scientific and medical publications
News from the EMA
Winners of the Geoff Hall Scholarship Essay Competition
Creative medical writing: An oxymoron?
Creative medical writing - An oxymoron?
An interview with Chris Winchester
Journal Watch
In the Bookstores
Good Writing Practice
Medical Devices
Getting Your Foot in the Door
Out on Our Own
Upcoming issues ofMedical Writing


The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board


Raquel Billiones


Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir


Jennifer Bell


Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer


Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha


Tiziana von Bruchhausen


Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk